RTS Establishes Testing Group

RTS Life Science, a supplier of automated sample management and pharmaceutical testing systems, has formed a new Pharmaceutical Testing Group.

Following the acquisition of Hatch Science, a Massachusetts-based life science company, earlier this year, the new Pharmaceutical Testing group integrates UK-developed products for inhaler and tablet testing with new U.S.-developed products for dissolution and content uniformity testing. The new group comprises both nations’ teams working together on a range of analytical development, quality control, dose content uniformity and dissolution testing systems.

Martin Schwalm, president of RTS, commented, “Our new combined range of tablet and inhaler testing helps us better serve the broad needs of our pharmaceutical development and QC customers.”

Mark Fish, director for inhalation automation at RTS, added, “Our new U.S. office and base will help us better serve and support the U.S. market with our proven automation solutions for inhaler testing.”